Immunotherapy with CpG-ODN in neoplastic meningitis: A phase I trial

TLR-9 agonists are immunostimulating agents that have antitumor effects in animal models. A phase I trial was conducted to define the safety profile of subcutaneous injections, combined with intrathecally administration of CpG-28, a TRL 9 agonist, in patients with neoplastic meningitis (NM). Cohorts...

全面介紹

Na minha lista:
書目詳細資料
發表在:Cancer Sci
Main Authors: Ursu, Renata, Taillibert, Sophie, Banissi, Claire, Vicaut, Eric, Bailon, Olivier, Le Rhun, Emilie, Guillamo, Jean-Sebastien, Psimaras, Dimitri, Tibi, Annick, Sacko, Adama, Marantidou, Athina, Belin, Catherine, Carpentier, Antoine F
格式: Artigo
語言:Inglês
出版: John Wiley & Sons, Ltd 2015
主題:
Original Articles
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4582991/
https://ncbi.nlm.nih.gov/pubmed/26094710
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12724
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍